140 related articles for article (PubMed ID: 38700792)
1. Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
Arroyo-Olarte RD; Flores-Castelán JC; Armas-López L; Escobedo G; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
Inflammation; 2024 May; ():. PubMed ID: 38700792
[TBL] [Abstract][Full Text] [Related]
2. STAT6 controls the stability and suppressive function of regulatory T cells.
Arroyo-Olarte RD; Rivera-Rugeles A; Nava-Lira E; Sánchez-Barrera Á; Ledesma-Soto Y; Saavedra R; Armas-López L; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
Eur J Immunol; 2023 May; 53(5):e2250128. PubMed ID: 36785881
[TBL] [Abstract][Full Text] [Related]
3. Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.
Kressler C; Gasparoni G; Nordström K; Hamo D; Salhab A; Dimitropoulos C; Tierling S; Reinke P; Volk HD; Walter J; Hamann A; Polansky JK
Front Immunol; 2020; 11():609891. PubMed ID: 33488615
[TBL] [Abstract][Full Text] [Related]
4. Induction of CD4
Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
[TBL] [Abstract][Full Text] [Related]
6. Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.
Alvarez-Salazar EK; Cortés-Hernández A; Arteaga-Cruz S; Alberú-Gómez J; Soldevila G
Front Immunol; 2020; 11():375. PubMed ID: 32300340
[TBL] [Abstract][Full Text] [Related]
7. Induction of CD4
Khosravi M; Bidmeshkipour A; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Immunol Res; 2018 Feb; 66(1):207-218. PubMed ID: 29143918
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
9. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.
Medof ME; Rieder SA; Shevach EM
J Immunol; 2023 Nov; 211(9):1359-1366. PubMed ID: 37756526
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2.
Knosp CA; Schiering C; Spence S; Carroll HP; Nel HJ; Osbourn M; Jackson R; Lyubomska O; Malissen B; Ingram R; Fitzgerald DC; Powrie F; Fallon PG; Johnston JA; Kissenpfennig A
J Immunol; 2013 Apr; 190(7):3235-45. PubMed ID: 23455506
[TBL] [Abstract][Full Text] [Related]
11. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
12. Human in vitro induced T regulatory cells and memory T cells share common demethylation of specific FOXP3 promoter region.
Bégin P; Schulze J; Baron U; Olek S; Bauer RN; Passerini L; Baccheta R; Nadeau KC
Clin Transl Allergy; 2015; 5():35. PubMed ID: 26500760
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
14. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
Wang L; Liu Y; Han R; Beier UH; Thomas RM; Wells AD; Hancock WW
Mol Cell Biol; 2013 Oct; 33(20):4106-15. PubMed ID: 23979593
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
16. Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells.
Kehrmann J; Tatura R; Zeschnigk M; Probst-Kepper M; Geffers R; Steinmann J; Buer J
Immunology; 2014 Jul; 142(3):384-95. PubMed ID: 24476360
[TBL] [Abstract][Full Text] [Related]
17. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
Lei J; Hasegawa H; Matsumoto T; Yasukawa M
J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
[TBL] [Abstract][Full Text] [Related]
19. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells.
Polansky JK; Schreiber L; Thelemann C; Ludwig L; Krüger M; Baumgrass R; Cording S; Floess S; Hamann A; Huehn J
J Mol Med (Berl); 2010 Oct; 88(10):1029-40. PubMed ID: 20574810
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
